These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29995318)

  • 1. Clinical value of hepatitis C virus core antigen levels in monitoring acute hepatitis C spontaneous clearance or treatment-induced clearance.
    Zhao N; Zheng W; Wu D; Wang X; Yang W; Yuan L; Niu Z; Jiang X; Huang F; Li Z
    J Med Virol; 2018 Dec; 90(12):1787-1792. PubMed ID: 29995318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection.
    Hashem M; Zaghla H; Zakaria Z; Allam WR; Sameea EA; Mikhail NN; Sobhy M; Galal IF; Mokhtar Y; Hamdy S; Galal G; Abdelwahab SF; Waked I
    J Med Virol; 2018 Dec; 90(12):1841-1847. PubMed ID: 30011346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.
    Liu CH; Liang CC; Liu CJ; Lin JW; Chen SI; Hung PH; Tsai HB; Lai MY; Chen PJ; Chen DS; Kao JH
    Clin Infect Dis; 2010 Sep; 51(5):541-9. PubMed ID: 20645865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diagnostic score for the prediction of spontaneous resolution of acute hepatitis C virus infection.
    Beinhardt S; Payer BA; Datz C; Strasser M; Maieron A; Dorn L; Grilnberger-Franz E; Dulic-Lakovic E; Stauber R; Laferl H; Aberle JH; Holzmann H; Krall C; Vogel W; Ferenci P; Hofer H
    J Hepatol; 2013 Nov; 59(5):972-7. PubMed ID: 23850880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection.
    Cho YK; Kim YN; Song BC
    Clin Mol Hepatol; 2014 Dec; 20(4):368-75. PubMed ID: 25548743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance.
    Spada E; Mele A; Berton A; Ruggeri L; Ferrigno L; Garbuglia AR; Perrone MP; Girelli G; Del Porto P; Piccolella E; Mondelli MU; Amoroso P; Cortese R; Nicosia A; Vitelli A; Folgori A
    Gut; 2004 Nov; 53(11):1673-81. PubMed ID: 15479691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial.
    Deterding K; Grüner N; Buggisch P; Wiegand J; Galle PR; Spengler U; Hinrichsen H; Berg T; Potthoff A; Malek N; Großhennig A; Koch A; Diepolder H; Lüth S; Feyerabend S; Jung MC; Rogalska-Taranta M; Schlaphoff V; Cornberg M; Manns MP; Wedemeyer H;
    Lancet Infect Dis; 2013 Jun; 13(6):497-506. PubMed ID: 23523674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
    Aebi-Popp K; Wandeler G; Salazar-Vizcaya L; Metzner K; Stöckle M; Cavassini M; Hoffmann M; Lüthi A; Suter F; Bernasconi E; Fehr J; Furrer H; Rauch A;
    HIV Med; 2018 Jul; 19(6):420-425. PubMed ID: 29573533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin.
    Pivert A; Payan C; Morand P; Fafi-Kremer S; Deshayes J; Carrat F; Pol S; Cacoub P; Perronne C; Lunel F
    J Clin Microbiol; 2006 Feb; 44(2):417-22. PubMed ID: 16455894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.
    Gerlach JT; Diepolder HM; Zachoval R; Gruener NH; Jung MC; Ulsenheimer A; Schraut WW; Schirren CA; Waechtler M; Backmund M; Pape GR
    Gastroenterology; 2003 Jul; 125(1):80-8. PubMed ID: 12851873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
    Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
    J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.
    Thong VD; Akkarathamrongsin S; Avihingsanon A; Theamboonlers A; Poovorawan Y; Tangkijvanich P
    Intervirology; 2015; 58(2):73-9. PubMed ID: 25677196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.
    Guobuzaite A; Chokshi S; Balciūniene L; Voinic A; Stikleryte A; Zagminas K; Ambrozaitis A; Naoumov N
    Medicina (Kaunas); 2008; 44(7):510-20. PubMed ID: 18695347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
    Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
    Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hepatitis C: prevention and treatment.
    Ozaras R; Tahan V
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.
    Peters L; Mocroft A; Soriano V; Rockstroh JK; Kirkby N; Reiss P; Katlama C; Zakharova N; Flisiak R; Lundgren JD;
    HIV Med; 2014 Nov; 15(10):615-20. PubMed ID: 24814468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virus.
    Pérez-García A; Aguinaga A; Navascués A; Castilla J; Ezpeleta C
    Int J Infect Dis; 2019 Dec; 89():131-136. PubMed ID: 31580940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection.
    Hung CH; Lee CM; Lu SN; Wang JH; Tung HD; Chen CH; Changchien CS
    J Gastroenterol Hepatol; 2005 May; 20(5):727-32. PubMed ID: 15853986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.